Cannabis for Anxiety in Australia — CBD, THC & What the Research Says (2026)

Anxiety disorders affect more than 3.3 million Australians — making them the most common mental health condition in the country. Despite a wide range of pharmaceutical treatments, roughly 40% of people with anxiety disorders do not achieve satisfactory relief from first-line medications. It is against this backdrop that medicinal cannabis has become one of the fastest-growing areas of interest in Australian mental health care.

But cannabis and anxiety have a complicated, paradoxical relationship. The same plant that helps thousands of Australians manage their anxiety every day can trigger acute panic in others. Understanding why — and knowing how to navigate that complexity — is the difference between a treatment that works and one that makes things worse.

This is a complete, evidence-based guide to cannabis for anxiety in Australia, written for patients and caregivers who want clarity without the marketing spin.

How anxiety works — and where cannabis fits in

Anxiety is not a single condition. It is a family of disorders — generalised anxiety disorder (GAD), social anxiety disorder (SAD), post-traumatic stress disorder (PTSD), panic disorder, obsessive-compulsive disorder (OCD) and specific phobias — each with overlapping but distinct neurobiology.

What they share is dysregulation of the brain’s fear and threat-detection circuits: the amygdala, prefrontal cortex and hippocampus. The neurotransmitters most involved include serotonin (5-HT), GABA (the brain’s primary inhibitory signal) and norepinephrine. Almost every pharmaceutical anxiolytic — SSRIs, SNRIs, benzodiazepines, buspirone — targets one or more of these pathways.

Where does cannabis fit?

The endocannabinoid system (ECS) is a neuromodulatory network that runs through virtually every brain region involved in anxiety. It consists of two receptor types (CB1 and CB2), endogenous ligands (anandamide and 2-AG), and the enzymes that synthesise and break them down.

CB1 receptors are densely expressed in the amygdala, prefrontal cortex, hippocampus and hypothalamus — precisely the regions that malfunction in anxiety disorders. Research published in Neuropsychopharmacology (2015) demonstrated that the ECS acts as a “stress buffer,” with endocannabinoid release dampening fear responses after a threat has passed.

When the ECS is chronically underactive — due to genetics, prolonged stress or trauma — this dampening fails, and anxiety can become persistent. Both THC and CBD interact with the ECS, though in very different ways.

The cannabis-anxiety paradox: why the same plant helps and harms

Cannabis is simultaneously one of the most commonly used substances for managing anxiety and one of the most common triggers of anxiety-related adverse effects. Understanding why requires looking at three variables: the compound (THC vs CBD), the dose, and the individual.

THC and anxiety: a dose-dependent curve

THC activates CB1 receptors directly and produces its effects through this agonism. Its relationship with anxiety follows an inverted-U dose-response curve:

• Very low doses (1–2.5mg THC): Mild euphoria, reduced rumination, lowered social inhibition. Many people find this dose range helpful for situational anxiety.
• Low to moderate doses (5–15mg THC): Relaxation in most people; first signs of dose-dependent anxiety in sensitive individuals.
• Moderate to high doses (15mg+ THC): Significantly increased risk of acute anxiety, paranoia, racing thoughts and increased heart rate — particularly in people who are THC-naive, genetically sensitive or already in an anxious state.

This explains one of the most common patterns seen by Australian medicinal cannabis prescribers: a patient who found cannabis helpful at a low dose begins increasing their dose seeking more benefit, and instead develops worsening anxiety.

Key genetic factor: Polymorphisms in the FAAH gene (which encodes the enzyme that breaks down anandamide) affect how strongly a person responds to cannabis. People with reduced FAAH activity have higher baseline anandamide, and may be more sensitive to THC’s anxiogenic effects at higher doses.

CBD and anxiety: a more consistent picture

CBD does not bind directly to CB1 receptors as an agonist. Instead, it acts through multiple mechanisms relevant to anxiety:

• 5-HT1A partial agonism: CBD activates serotonin receptors in a similar way to buspirone, producing anxiolytic effects through the same pathway as some non-benzodiazepine anxiety treatments.
• FAAH inhibition: CBD slows the breakdown of anandamide, effectively boosting the brain’s own endocannabinoid signalling.
• TRPV1 modulation: CBD desensitises TRPV1 receptors, which are involved in stress and pain responses.
• Neurogenesis support: CBD has demonstrated the ability to promote new neuron growth in the hippocampus — a region consistently found to be reduced in volume in anxiety and depression.

Unlike THC, CBD does not produce significant psychoactive effects at standard doses. This means it can be taken during the day without impairment, making it a practical option for the majority of people with anxiety.

What the clinical evidence shows

The evidence base for cannabis in anxiety is growing rapidly, though it remains stronger for some conditions than others.

Generalised anxiety disorder (GAD): A 2019 retrospective study in The Permanente Journal followed 72 adults given CBD capsules (25–75mg/day). After one month, 79.2% reported decreased anxiety. The effect was maintained at the two-month follow-up in most participants.

Social anxiety disorder (SAD): A landmark 2011 randomised controlled trial published in Neuropsychopharmacology administered 600mg CBD to participants with SAD before a simulated public speaking test. CBD significantly reduced anxiety, cognitive impairment and discomfort during the test — approaching the performance of a control group without SAD. A 2019 open-label trial in Japanese adolescents with SAD found that 300mg/day CBD for four weeks significantly reduced social anxiety scores.

PTSD: Multiple studies and case series support cannabis — particularly THC-containing formulations — for PTSD-related anxiety and nightmares. A 2019 open-label pilot study found significant reductions in PTSD symptom scores after 8 weeks of cannabis treatment. Australian specialist prescribers frequently treat PTSD with THC-CBD combination oils, particularly for veterans and first responders.

Panic disorder: Evidence is thinner but consistent with CBD’s general anxiolytic profile. Animal studies show CBD reduces the frequency and intensity of conditioned fear responses — the mechanism behind panic disorder. Human trial data specifically for panic disorder is limited; prescribers typically extrapolate from GAD data.

Important limitations: Most positive studies use doses (150–600mg CBD/day) significantly higher than what over-the-counter products in Australia contain. The evidence for THC-dominant products is more mixed. Long-term RCT data is still lacking for most anxiety indications.

CBD vs THC for anxiety: the complete comparison

	CBD	Low-dose THC	High-dose THC
Psychoactive	No	Mildly	Yes
Anxiety risk	Very low	Low–moderate	High
Evidence for anxiety	Strong (high doses)	Limited	Often counterproductive
Best for	GAD, SAD, PTSD, daytime use	Situational anxiety, experienced users only	Not recommended for anxiety
Dependency risk	Very low	Low	Moderate with chronic use
OTC availability (Australia)	Yes (up to 150mg/day)	No — prescription required	No — prescription required
Impairment	None at standard doses	Mild	Significant

The practical verdict: For anxiety, CBD-dominant or high-CBD:low-THC products are the standard recommendation in Australian medicinal cannabis practice. A CBD:THC ratio of at least 10:1 is a common starting point, with pure CBD appropriate for people who cannot tolerate any THC or are new to cannabis medicine.

Small amounts of THC alongside CBD may enhance the anxiolytic effect via the “entourage effect,” but this benefit must be weighed carefully against the risk of THC-induced anxiety — particularly at higher doses or in sensitive individuals.

Terpenes that reduce anxiety

Terpenes are the aromatic compounds in cannabis that give each strain its distinctive smell — and have real biological activity of their own. When choosing a cannabis product for anxiety, the terpene profile can meaningfully influence the experience.

Linalool — also the primary terpene in lavender, linalool has among the strongest evidence for anxiolytic activity of any terpene. It modulates GABA activity through the same mechanisms as benzodiazepines — without the sedation or dependence risk. Strains and oils high in linalool have a floral, faintly spicy aroma. Look for linalool concentrations of 0.5% or higher.

Caryophyllene — the only terpene known to bind directly to CB2 receptors, producing anti-inflammatory and anxiolytic effects. Particularly valuable for people whose anxiety is accompanied by physical tension or inflammation. Common in peppery, woody-smelling products. Also found in black pepper and cloves — which is why biting a peppercorn is sometimes used as a folk remedy for cannabis-induced anxiety.

Limonene — present in citrus rinds and some cannabis strains. Demonstrated anxiolytic and antidepressant effects in preclinical models. More stimulating than sedating, making it better suited to daytime anxiety than sleep-related issues. Look for a bright, citrusy scent.

Myrcene — the most common terpene in commercial cannabis. Earthy and musky in aroma. Primarily a muscle relaxant and mild sedative — more useful for anxiety that manifests as physical tension or anxiety-driven insomnia than for cognitive or social anxiety.

Avoid for daytime anxiety: High-pinene strains can be alerting in some people and may worsen anxious rumination. High-terpinolene products tend toward the energising end of the spectrum.

Best cannabis products for anxiety in Australia

High-dose CBD oil (first choice)

The most evidence-backed option for most anxiety presentations. Look for full-spectrum or broad-spectrum oils — not isolate — to preserve the entourage effect from minor cannabinoids and terpenes. Standard prescription doses in Australia range from 50mg CBD twice daily (starting dose) up to 300–600mg/day for treatment-resistant cases.

Onset: 30–90 minutes when swallowed; 15–40 minutes when held under the tongue (sublingual). Take consistently at the same times each day for steady-state plasma levels, which produce a more stable anxiolytic effect than peaks and troughs.

Balanced tinctures (CBD:THC 10:1 to 20:1)

For people who have tried CBD-only and want to explore the entourage effect. A 10:1 ratio means 10 parts CBD for every 1 part THC — at typical doses, the psychoactive effect of the THC is minimal but potentially additive to the anxiolytic benefit. These require a prescription in Australia.

Low-THC flower (vaporised) — for acute episodes

Some people find that vaporising a small amount of high-CBD, low-THC flower provides rapid relief from acute anxiety spikes — such as before a social event or during a panic episode. Onset is 5–15 minutes, making it the fastest-acting format. The key is strict dose control: one or two inhalations of a low-THC strain (under 10% THC, 5–10% CBD).

Important: combustion (smoking) produces carbon monoxide and irritants that can increase physiological arousal and worsen anxiety. Always vaporise rather than smoke if using flower for anxiety.

Topicals — for physical anxiety symptoms

CBD-infused creams and balms applied to the temples, jaw, neck or shoulders can reduce the physical manifestations of anxiety — tension headaches, jaw clenching, shoulder tightness. While topicals are unlikely to affect cognitive or emotional anxiety, they can meaningfully reduce the somatic experience.

What to avoid

• High-THC products: THC above 15–20% significantly raises the risk of anxiety and panic attacks, especially in THC-naive users or those with GAD
• Edibles with unclear dosing: the delayed onset (60–120 minutes) commonly leads to re-dosing before the first dose has fully kicked in, resulting in overconsumption and acute anxiety
• Concentrates (dabs, waxes): high THC delivery rate, inappropriate for anxiety treatment
• Sativa-dominant strains with high limonene/pinene: the energising terpene profile can exacerbate anxious thoughts in some people
• Smoking: produces irritants that increase physical arousal

Strains with lower anxiety risk

When browsing cannabis flower specifically for anxiety management, look for:

• Indica-dominant or balanced hybrid genetics: generally produce more body-relaxing, less cerebral effects
• THC under 18%: lower THC content substantially reduces anxiety risk
• CBD present: even 3–5% CBD provides meaningful buffering of THC’s anxiogenic effects
• Terpene profile: high myrcene, linalool or caryophyllene, lower pinene and terpinolene

Ask your dispensary for the Certificate of Analysis (CoA) for any flower product — this gives you exact cannabinoid percentages and, in better products, terpene profiles verified by a third-party laboratory.

When cannabis worsens anxiety: recognising the risk

Cannabis is not a universal anxiety remedy. It is explicitly contraindicated or requires extreme caution in:

People with a personal or family history of psychosis or schizophrenia. THC can trigger or accelerate psychotic episodes in genetically vulnerable individuals. This is not dose-dependent — even low doses pose risk. CBD-only products are generally considered safer in this population, but specialist guidance is essential.

Young people under 25. The developing brain is significantly more vulnerable to both THC’s anxiogenic effects and its long-term impact on anxiety regulation. Australian prescribing guidelines explicitly caution against THC-containing products in this age group without compelling clinical indication.

People who are THC-naive. First exposure to THC commonly produces anxiety, even at low doses, simply due to unfamiliarity with the sensations. If trying THC for the first time, do so in a calm, safe environment at the lowest possible dose.

People with panic disorder. THC can closely mimic the physical sensations of a panic attack (elevated heart rate, depersonalisation, derealization). For this group, CBD-only products are strongly preferred.

People taking stimulant medications or with cardiovascular conditions. THC increases heart rate — this can combine problematically with stimulants or in people with arrhythmia or hypertension.

Cannabis use disorder and anxiety. Regular high-THC use can paradoxically increase baseline anxiety over time. Withdrawal from heavy cannabis use typically includes significant anxiety as a symptom — lasting days to weeks. Some people experience more anxiety between cannabis uses than they did before starting, creating a cycle of dependence.

Drug interactions: cannabis and anxiety medications

If you are already taking medication for anxiety, speak to your prescribing doctor before adding cannabis. Key interactions include:

Medication class	Interaction	Clinical significance
SSRIs / SNRIs	CBD inhibits CYP2D6 and CYP3A4 — may increase SSRI blood levels	Monitor for serotonin-related side effects; dose adjustment may be needed
Benzodiazepines	Additive CNS depression with THC; CBD may inhibit benzo metabolism	Use with extreme caution; increased sedation and impairment risk
Buspirone	CBD and buspirone both act on 5-HT1A — potential additive or competitive effects	Generally considered low risk but monitor response
Beta-blockers	THC can cause tachycardia, potentially counteracting beta-blocker effect	Monitor heart rate; use low-THC or CBD-only products
Antiepileptics	CBD inhibits CYP enzymes that metabolise some antiepileptics	May require dose adjustments under specialist supervision

Read our full guide on cannabis and antidepressants if you are currently on an SSRI or SNRI.

Dosing CBD for anxiety: a practical starting guide

Start low, go slow. Anxiety patients often respond to lower doses than trial participants. Starting too high — especially with any THC present — can trigger the very anxiety you are trying to treat.

Week 1–2 (CBD lead-in): Begin with 25–50mg CBD per day, split into two doses (morning and evening). Use a consistent product — switching between brands at this stage makes it impossible to evaluate the effect. Many people with mild-to-moderate anxiety find significant relief at this dose range.

Week 3–4 (first assessment): If insufficient response, increase to 75–100mg CBD daily. Keep a simple anxiety diary (rate anxiety 0–10 each day) to track changes. A meaningful response is typically a 30% or greater reduction in daily anxiety scores.

Week 5–8 (titration if needed): For treatment-resistant anxiety or PTSD, doses up to 300–600mg CBD have been used in clinical settings. These doses require a prescription; over-the-counter products are capped at 150mg/day in Australia.

Adding THC (under medical supervision only): If a CBD-only approach provides partial but insufficient benefit, a small THC component (1–5mg/day) can be added cautiously under medical supervision. This must be done incrementally and with close monitoring.

Anxiety-specific cannabis products available in Australia

Over-the-counter (no prescription required): Since February 2021, certain CBD products containing up to 150mg CBD per day are available from Australian pharmacies as pharmacist-only (Schedule 3) medicines. These are appropriate for mild-to-moderate anxiety and represent the lowest-risk, most accessible entry point. Ask your pharmacist; not all pharmacies stock them.

Prescription medicinal cannabis: For higher-dose CBD or any THC-containing product, you need a TGA-compliant prescription:

1. Book a telehealth consultation with a cannabis-friendly GP — Alternaleaf, Polln, Leafio and similar platforms specialise in this. Initial appointments: $50–150.
2. Discuss your anxiety history: what conditions you’ve been diagnosed with, treatments tried previously, current medications, alcohol and drug use history, and family history of psychosis.
3. Receive your prescription — most are issued under the TGA’s Special Access Scheme B (SAS-B), which requires no separate government approval. Some GPs hold Authorised Prescriber status for specific products.
4. Pharmacy dispensing — medications are dispensed to a registered pharmacy or delivered directly to your door. Turnaround is typically 2–7 business days.

Conditions commonly approved for anxiety prescriptions in Australia: Generalised anxiety disorder, social anxiety disorder, PTSD, panic disorder, adjustment disorder, and anxiety secondary to chronic pain, insomnia or cancer.

Typical ongoing cost: $50–150 for the initial telehealth consultation; $100–250/month for ongoing medication depending on formulation, dose and brand.

Combining cannabis with other anxiety treatments

Cannabis works best as part of a comprehensive approach to anxiety, not as a standalone replacement for established treatments.

Cognitive Behavioural Therapy (CBT): The gold standard for most anxiety disorders. CBT and cannabis may complement each other well — cannabis can reduce the intensity of anxiety symptoms enough for CBT techniques to become accessible. Some patients report being able to engage more productively with exposure therapy when their baseline anxiety is lowered by CBD.

Exercise: Among the most robustly evidence-based interventions for anxiety. Regular aerobic exercise (3–5 sessions per week, 30+ minutes) produces reliable reductions in anxiety comparable to pharmaceutical treatment in several meta-analyses. Cannabis may help with motivation and recovery, particularly in people whose anxiety prevents them from starting an exercise habit.

Sleep: Anxiety and poor sleep drive each other in a bidirectional relationship. Cannabis for sleep addresses one of the most common anxiety triggers. Treating insomnia frequently reduces daytime anxiety meaningfully.

Reducing alcohol and caffeine: Alcohol is commonly used to self-medicate anxiety and reliably worsens it in the medium term. Caffeine directly increases physiological arousal and can trigger or worsen anxiety, particularly at higher doses. Reducing both before starting cannabis makes it much easier to evaluate the cannabis’s effect.

Mindfulness and breathwork: Complementary to cannabis. Diaphragmatic breathing (slow, deep breaths) activates the parasympathetic nervous system and produces rapid anxiety reduction — and can be used to manage acute anxiety episodes without reaching for a higher cannabis dose.

What to realistically expect

Timeline:

• CBD oil typically shows initial effects within 1–2 weeks of consistent use
• Full therapeutic benefit may take 4–8 weeks to establish at stable doses
• THC-containing products may work faster for some symptoms but require more careful dose management

Signs it is working:

• Reduced frequency and intensity of anxious thoughts
• Lower physiological arousal (heart rate, muscle tension, gut symptoms)
• Better sleep onset and quality
• Improved ability to engage socially or at work
• Reduced reliance on other coping mechanisms (alcohol, avoidance)

Signs to reassess:

• Anxiety is worse than before starting
• You are increasing doses frequently to maintain the same effect
• You feel dependent on cannabis to function normally
• You are experiencing paranoia, memory impairment or significant psychoactive effects

If any of these signs are present, speak to your prescribing doctor before continuing.

Frequently asked questions

Is CBD legal for anxiety in Australia? Yes. Low-dose CBD products (up to 150mg CBD/day) are available at Australian pharmacies without a prescription as pharmacist-only medicines. Higher-dose CBD and all THC-containing products require a valid prescription from a registered GP under the TGA’s SAS-B or Authorised Prescriber framework.

Does weed make anxiety worse? It depends entirely on the product, dose and individual. High-THC products frequently worsen anxiety, particularly in THC-sensitive individuals, at high doses, or in unfamiliar settings. High-CBD, low-THC products generally reduce anxiety. Starting with CBD-only or a high-CBD ratio product is the safest approach for people with anxiety.

How much CBD should I take for anxiety? Clinical trials for anxiety have used doses from 150mg to 600mg CBD per day. Australian prescribers typically start at 25–50mg twice daily and adjust over 4–8 weeks. Over-the-counter products contain up to 150mg/day. Always titrate slowly and keep an anxiety diary to track your response.

Can I use cannabis for anxiety while on antidepressants? Some interactions exist, particularly with SSRIs and SNRIs via the CYP450 enzyme pathway. CBD can raise blood levels of some antidepressants. Always disclose cannabis use to your prescribing doctor before starting. Read our full guide on cannabis and antidepressants.

What is the best cannabis product for anxiety in Australia? For most people, a high-CBD full-spectrum oil (CBD:THC ratio of at least 10:1) is the safest and most effective starting point. If you have mild anxiety and prefer no prescription, pharmacist-only CBD products are a good first step. Browse CBD-dominant products in our shop to see what’s available.

Will cannabis make me high if I take it for anxiety? High-CBD, low-THC products produce little to no psychoactive effect. Pure CBD products are non-intoxicating. THC-containing products may produce mild psychoactive effects at therapeutic doses — most people describe this as a relaxed, calming sensation rather than an intense recreational “high.”

How long does CBD take to work for anxiety? Most people notice initial effects within 1–2 weeks of consistent daily use. The full therapeutic effect typically takes 4–8 weeks to establish. CBD is not a fast-acting anxiolytic in the way that benzodiazepines are — it works through a slow accumulation of neurochemical changes rather than immediate receptor activation.

Can I drive after taking cannabis for anxiety? CBD-only products at standard therapeutic doses do not impair driving. THC-containing products can impair driving and it is illegal to drive with THC present in your blood in Australia, regardless of how you feel. If your prescription includes THC, do not drive — speak to your prescriber about timing to allow safe commuting.

Is medicinal cannabis covered by Medicare or PBS in Australia? No. Medicinal cannabis is not currently listed on the Pharmaceutical Benefits Scheme (PBS) in Australia, meaning the full cost is paid out of pocket. This includes the initial telehealth consultation fee, the prescription and the medication itself. Some private health insurers may offer partial reimbursement — check your policy.

What if cannabis doesn’t help my anxiety? Cannabis is not effective for everyone with anxiety. If you have not seen meaningful improvement after 8–12 weeks of well-managed cannabis use (appropriate dose, consistent product, monitored by a prescriber), it may not be the right treatment for your specific anxiety presentation. Return to your prescriber to discuss alternatives — including higher doses, different ratios, or non-cannabis pharmaceutical options.

Shop cannabis for anxiety

Once you have a prescription, explore the product formats most commonly used for anxiety management:

• Cannabis Concentrates & CBD Oils — Full-spectrum CBD oils and high-CBD:THC ratio tinctures are the most prescribed format for anxiety. Precise dosing, predictable onset, no inhalation required.
• Cannabis Flower — High-CBD Strains — Low-THC, high-CBD flower (e.g. CBD:THC ratio ≥ 10:1) for patients who prefer inhalation. Fast onset with a manageable, non-intoxicating effect profile.
• Cannabis Vaporizers — 510-thread CBD cartridges and disposable vape pens for discreet, fast-acting relief. Preferred by patients with acute anxiety episodes.
• Cannabis Edibles Australia — CBD capsules and gummies for consistent, long-lasting background relief. Slow onset (1–2 hours) makes dosing accuracy critical — start low.
• CBD Topicals Australia — CBD balms and roll-ons for tension headaches and muscle tightness associated with anxiety. Non-psychoactive and no prescription required for Schedule 3 products.
• Pre-Rolls Online Australia — High-CBD, low-THC pre-rolls for patients who want convenience without the preparation. Suitable for mild-to-moderate anxiety presentations.

Related guides

• Cannabis for sleep Australia — Anxiety and sleep problems frequently co-occur; read the sleep guide alongside this one
• Cannabis for chronic pain Australia — Pain and anxiety share overlapping endocannabinoid pathways
• THC vs CBD Australia — Understand which cannabinoid suits an anxiety presentation
• Cannabis and antidepressants Australia — Key interactions to know before combining with SSRIs or SNRIs
• Terpenes cannabis guide Australia — Why linalool and myrcene matter for anxiety relief
• How to buy cannabis online Australia — Step-by-step from prescription to delivery

The bottom line

Cannabis can be an effective adjunct treatment for anxiety — particularly high-CBD, low-THC products under medical supervision. The evidence base is strongest for CBD, with growing clinical support for balanced THC:CBD ratios in treatment-resistant presentations. Always start low, titrate slowly, and work with a registered prescriber.

Ready to start? Browse CBD-dominant anxiety products or explore all 800+ products from 200+ Australian brands — with same-day delivery in Sydney, Melbourne, Brisbane, Perth, Adelaide, Gold Coast, Canberra and Darwin.